DuPont de Nemours (DD) Financials

$77.67 -0.16 (-0.21%)

Closing price 08/28/2025 03:59 PM Eastern

Extended Trading

$77.74 +0.08 (+0.10%)

As of 08:12 AM Eastern

Annual Income Statements for DuPont de Nemours

This table shows DuPont de Nemours' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	7,345	3,978	1,159	3,845	498	-2,951	6,467	5,868	423	703
Consolidated Net Income / (Loss)	7,783	4,404	1,291	4,000	600	-2,923	6,515	5,917	462	738
Net Income / (Loss) Continuing Operations	7,783	4,404	233	405	-124	-1,349	1,207	1,061	533	778
Total Pre-Tax Income	9,930	4,413	-1,525	600	-126	-1,259	1,444	1,448	504	1,192
Total Operating Income	5,486	4,456	-951	116	312	-1,387	1,739	1,674	747	1,574
Total Gross Profit	11,033	10,490	2,114	7,292	5,410	4,065	4,595	4,615	4,233	4,507
Total Revenue	48,778	48,158	11,672	22,594	15,436	11,128	12,566	13,017	12,068	12,386
Operating Revenue	48,778	48,158	11,672	22,594	15,436	11,128	12,566	13,017	12,068	12,386
Total Cost of Revenue	37,745	37,668	9,558	15,302	10,026	7,063	7,971	8,402	7,835	7,879
Operating Cost of Revenue	37,745	37,668	9,558	15,302	10,026	7,063	7,971	8,402	7,835	7,879
Total Operating Expenses	5,547	6,034	3,065	7,176	5,098	5,452	2,856	2,941	3,486	2,933
Selling, General & Admin Expense	2,948	2,953	1,615	3,028	2,057	1,492	1,602	1,467	1,408	1,552
Research & Development Expense	1,598	1,593	657	1,070	689	565	557	536	508	531
Amortization Expense	419	544	505	1,044	701	542	566	590	600	595
Impairment Charge	-	-	0.00	0.00	242	1,862	0.00	0.00	804	0.00
Restructuring Charge	559	595	288	147	152	991	131	348	166	255
Total Other Income / (Expense), net	4,444	-43	-574	484	-438	128	-295	-226	-243	-382
Interest Expense	946	858	1,007	55	667	672	525	492	396	366
Interest & Investment Income	674	442	367	447	85	168	85	75	51	60
Other Income / (Expense), net	4,716	373	66	92	144	632	145	191	102	-76
Income Tax Expense	2,147	9.00	-1,758	195	-2.00	90	237	387	-29	414
Net Income / (Loss) Discontinued Operations	0.00	0.00	1,058	3,595	724	-1,574	5,308	4,856	-71	-40
Net Income / (Loss) Attributable to Noncontrolling Interest	98	86	132	155	102	28	48	49	39	35
Basic Earnings per Share	$6.45	$3.57	$2.18	$4.99	$0.67	($4.01)	$11.92	$11.77	$0.94	$1.68
Weighted Average Basic Shares Outstanding	1.13B	1.11B	526.60M	767M	746.30M	735.50M	542.70M	498.50M	449.90M	419.20M
Diluted Earnings per Share	$6.15	$3.52	$2.15	$4.96	$0.67	($4.01)	$11.89	$11.75	$0.94	$1.67
Weighted Average Diluted Shares Outstanding	1.24B	1.12B	532.70M	771.80M	746.30M	735.50M	544.20M	499.40M	451.20M	420.60M
Weighted Average Basic & Diluted Shares Outstanding	-	1.11B	2.33B	770.50M	739.39M	1.08B	512.91M	458.34M	417.58M	418.05M
Cash Dividends to Common per Share	$1.72	$1.84	$0.46	$0.38	$2.16	$1.20	$1.20	$1.32	$1.44	$1.52

This table shows DuPont de Nemours' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	4,226	257	-131	319	-22	189	178	454	-118	-589	59
Consolidated Net Income / (Loss)	4,238	265	-117	328	-14	197	185	462	-106	-582	70
Net Income / (Loss) Continuing Operations	105	273	269	291	-300	183	176	480	-61	-548	238
Total Pre-Tax Income	193	356	356	408	-616	267	296	586	43	-429	306
Total Operating Income	234	407	412	444	-516	313	459	460	342	-446	373
Total Gross Profit	1,056	1,035	1,064	1,104	1,030	1,013	1,175	1,194	1,125	1,146	1,216
Total Revenue	3,104	3,018	3,094	3,058	2,898	2,931	3,171	3,192	3,092	3,066	3,257
Operating Revenue	3,104	3,018	3,094	3,058	2,898	2,931	3,171	3,192	3,092	3,066	3,257
Total Cost of Revenue	2,048	1,983	2,030	1,954	1,868	1,918	1,996	1,998	1,967	1,920	2,041
Operating Cost of Revenue	2,048	1,983	2,030	1,954	1,868	1,918	1,996	1,998	1,967	1,920	2,041
Total Operating Expenses	822	628	652	660	1,546	700	716	734	783	1,592	843
Selling, General & Admin Expense	337	340	358	360	350	384	418	387	363	369	405
Research & Development Expense	123	127	125	128	128	125	134	134	138	137	142
Amortization Expense	143	147	146	155	152	149	151	149	146	146	140
Other Operating Expenses / (Income)	-	0.00	6.00	9.00	-	3.00	5.00	43	-	125	154
Impairment Charge	-	-	-	-	-	0.00	0.00	-	-	768	0.00
Restructuring Charge	247	14	17	8.00	127	39	8.00	21	187	47	2.00
Total Other Income / (Expense), net	-41	-51	-56	-36	-100	-46	-163	126	-299	17	-67
Interest Expense	122	95	98	102	101	96	99	87	84	83	84
Interest & Investment Income	13	15	14	11	11	12	23	14	11	-1.00	30
Other Income / (Expense), net	68	29	28	55	-10	38	-87	199	-226	101	-13
Income Tax Expense	88	83	87	117	-316	84	120	106	104	119	68
Net Income / (Loss) Discontinued Operations	4,133	-8.00	-386	37	286	14	9.00	-18	-45	-34	-168
Net Income / (Loss) Attributable to Noncontrolling Interest	12	8.00	14	9.00	8.00	8.00	7.00	8.00	12	7.00	11
Basic Earnings per Share	$8.53	$0.56	($0.29)	$0.71	($0.04)	$0.45	$0.43	$1.09	($0.29)	($1.41)	$0.14
Weighted Average Basic Shares Outstanding	498.50M	458.80M	459.20M	451.70M	449.90M	422.80M	417.80M	417.90M	419.20M	418.50M	418.90M
Diluted Earnings per Share	$8.52	$0.56	($0.28)	$0.70	($0.04)	$0.45	$0.42	$1.08	($0.28)	($1.41)	$0.14
Weighted Average Diluted Shares Outstanding	499.40M	460.20M	460.30M	453.40M	451.20M	424.30M	419.30M	419.50M	420.60M	418.50M	419.70M
Weighted Average Basic & Diluted Shares Outstanding	458.34M	459.02M	459.06M	430.04M	417.58M	418.10M	417.50M	417.96M	418.05M	418.50M	418.72M
Cash Dividends to Common per Share	-	$0.36	$0.72	-	-	$0.38	$0.76	-	-	$0.41	$0.82

This table details how cash moves in and out of DuPont de Nemours' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	2,923	-1,879	878	2,012	-12,445	7,198	-6,699	1,696	-969	-911
Net Cash From Operating Activities	7,607	-2,957	878	5,503	1,409	4,095	1,846	1,249	2,191	2,321
Net Cash From Continuing Operating Activities	7,607	-2,957	878	5,503	1,409	4,095	1,846	1,249	2,191	2,321
Net Income / (Loss) Continuing Operations	7,783	4,404	1,291	4,000	600	-2,923	1,207	1,061	533	778
Consolidated Net Income / (Loss)	7,783	4,404	1,291	4,000	600	-2,923	6,515	5,917	462	738
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	5,308	4,856	-71	-40
Depreciation Expense	2,521	2,862	1,060	2,170	3,195	3,094	1,112	1,135	1,147	1,194
Non-Cash Adjustments To Reconcile Net Income	-3,187	23	0.00	0.00	2,109	3,448	-3.00	65	1,047	290
Changes in Operating Assets and Liabilities, net	490	-10,246	-1,473	-667	-4,748	476	-482	-1,012	-536	59
Net Cash From Investing Activities	-1,350	5,092	0.00	0.00	-2,313	-202	-2,298	9,004	172	-849
Net Cash From Continuing Investing Activities	-1,350	5,092	0.00	0.00	-2,313	-202	-2,298	9,004	172	-849
Purchase of Property, Plant & Equipment	-3,749	-3,917	0.00	0.00	-2,472	-1,194	-788	-662	-619	-579
Acquisitions	-926	-137	0.00	0.00	-180	-70	-2,346	5.00	-1,761	-321
Purchase of Investments	-1,246	-577	0.00	0.00	-197	-1.00	-2,001	-1,317	-32	0.00
Divestitures	3,911	306	0.00	0.00	299	1,033	797	10,951	1,244	8.00
Sale and/or Maturity of Investments	660	842	0.00	0.00	242	1.00	2,001	15	1,334	0.00
Other Investing Activities, net	0.00	8,575	0.00	0.00	-5.00	29	39	12	6.00	43
Net Cash From Financing Activities	-3,132	-4,014	0.00	-3,491	-11,550	3,238	-7,589	-7,646	-2,989	-1,847
Net Cash From Continuing Financing Activities	-3,132	-4,014	0.00	-3,491	-11,550	3,238	-7,589	-7,646	-2,989	-1,847
Repayment of Debt	-1,284	-623	0.00	0.00	-4,274	-3,915	-4,876	-3,254	-301	-688
Payment of Dividends	-2,540	-2,840	0.00	-3,491	-8,953	-932	-659	-678	-688	-661
Issuance of Debt	1,383	32	0.00	0.00	4,005	8,275	0.00	600	0.00	0.00
Issuance of Common Equity	525	398	0.00	0.00	85	57	115	88	27	50
Other Financing Activities, net	-50	-65	0.00	0.00	-84	-247	-2,169	-4,402	-2,027	-548
Effect of Exchange Rate Changes	-202	-	-	-	9.00	67	-72	-148	-37	-62
Other Net Changes in Cash	-	-	-	-	-	-	1,414	-763	-306	-474
Cash Interest Paid	1,137	1,192	1,254	2,116	969	647	499	494	408	394
Cash Income Taxes Paid	1,405	1,592	1,368	2,199	722	495	561	844	394	316

This table details how cash moves in and out of DuPont de Nemours' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Change in Cash & Equivalents	1,838	-136	1,360	-3,249	1,056	-456	-838	177	206	-89	76
Net Cash From Operating Activities	185	405	400	740	646	493	527	737	564	382	381
Net Cash From Continuing Operating Activities	185	405	400	740	646	493	527	737	564	382	381
Net Income / (Loss) Continuing Operations	105	273	269	291	-300	183	176	480	-61	-548	238
Consolidated Net Income / (Loss)	4,238	265	-117	328	-14	197	185	462	-106	-582	70
Net Income / (Loss) Discontinued Operations	4,133	-8.00	-386	37	286	14	9.00	-18	-45	-34	-168
Depreciation Expense	274	277	282	294	294	291	298	306	299	293	296
Non-Cash Adjustments To Reconcile Net Income	81	14	38	12	983	33	101	-156	312	742	23
Changes in Operating Assets and Liabilities, net	-275	-159	-189	143	-331	-14	-48	107	14	-105	-176
Net Cash From Investing Activities	9,133	-250	1,201	-1,870	1,091	-202	-100	-423	-124	-247	-111
Net Cash From Continuing Investing Activities	9,133	-250	1,201	-1,870	1,091	-202	-100	-423	-124	-247	-111
Purchase of Property, Plant & Equipment	-160	-232	-123	-119	-145	-207	-102	-109	-161	-249	-116
Other Investing Activities, net	8.00	-1.00	5.00	-6.00	8.00	0.00	10	10	23	2.00	5.00
Net Cash From Financing Activities	-7,185	-213	-164	-1,982	-630	-691	-840	-140	-176	-206	-184
Net Cash From Continuing Financing Activities	-7,185	-213	-164	-1,982	-630	-691	-840	-140	-176	-206	-184
Payment of Dividends	-151	-199	-165	-165	-159	-179	-158	-163	-161	-194	-171
Other Financing Activities, net	-4,377	-26	2.00	-2,001	-2.00	-517	-7.00	-2.00	-22	-16	-6.00
Effect of Exchange Rate Changes	43	-7.00	-22	-27	19	-25	-17	33	-53	13	31
Other Net Changes in Cash	-338	-71	-55	-110	-70	-31	-408	-30	-5.00	-31	-41

This table presents DuPont de Nemours' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	79,511	192,164	187,855	69,349	70,904	45,707	41,355	38,552	36,636
Total Current Assets	23,659	49,893	126,655	9,999	29,008	14,303	11,270	7,514	6,364
Cash & Equivalents	6,607	13,438	8,548	1,540	2,544	1,972	3,662	2,392	1,850
Restricted Cash	-	-	-	-	-	-	7.00	411	6.00
Accounts Receivable	8,978	16,893	3,391	3,802	2,421	2,159	2,518	2,370	2,199
Inventories, net	7,363	16,992	4,107	4,319	2,393	2,086	2,329	2,147	2,130
Prepaid Expenses	-	-	-	-	181	177	161	194	179
Plant, Property, & Equipment, net	23,486	36,247	9,917	10,143	6,867	5,753	5,731	5,884	5,768
Total Noncurrent Assets	32,366	106,024	51,283	49,207	35,029	25,651	24,354	25,154	24,504
Long-Term Investments	6,716	7,900	1,773	1,260	1,047	919	733	1,071	1,081
Goodwill	15,272	59,527	34,496	33,151	18,702	16,981	16,663	16,720	16,567
Intangible Assets	6,026	33,274	14,655	13,593	8,072	6,222	5,495	5,814	5,370
Noncurrent Deferred & Refundable Income Taxes	3,079	1,869	178	189	190	116	109	312	246
Other Noncurrent Operating Assets	565	2,774	134	1,014	812	1,360	1,251	1,237	1,204
Other Noncurrent Nonoperating Assets	-	-	-	-	6,206	53	103	0.00	36
Total Liabilities & Shareholders' Equity	79,511	192,164	187,855	69,349	70,904	45,707	41,355	38,552	36,636
Total Liabilities	52,282	90,237	91,955	27,793	31,834	18,657	14,338	13,827	12,843
Total Current Liabilities	12,604	26,128	73,312	8,346	12,226	4,931	3,733	3,098	4,801
Short-Term Debt	907	4,015	15	3,830	1.00	150	300	0.00	1,848
Accounts Payable	6,616	12,861	2,619	2,934	2,222	2,102	2,103	1,675	1,720
Accrued Expenses	4,481	8,409	1,129	1,342	1,084	1,040	951	1,269	1,031
Current Deferred & Payable Income Tax Liabilities	600	843	115	240	169	201	233	154	202
Total Noncurrent Liabilities	39,678	64,109	18,643	19,447	19,608	13,726	10,605	10,729	8,042
Long-Term Debt	20,456	30,056	12,624	13,617	15,611	10,632	7,774	7,800	5,323
Noncurrent Deferred & Payable Income Tax Liabilities	923	6,266	3,912	3,467	2,053	1,459	1,158	1,130	915
Noncurrent Employee Benefit Liabilities	11,375	18,581	1,343	1,172	1,110	762	522	565	523
Other Noncurrent Operating Liabilities	5,560	7,969	764	1,191	834	873	1,151	1,234	1,281
Commitments & Contingencies	-	-	-	-	-	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	27,229	101,927	95,900	41,556	39,070	27,050	27,017	24,725	23,793
Total Preferred & Common Equity	25,987	100,330	94,292	40,987	38,504	26,433	26,569	24,279	23,350
Total Common Equity	25,987	100,330	94,292	40,987	38,504	26,433	26,569	24,279	23,350
Common Stock	7,369	81,280	81,984	50,803	50,046	49,579	48,425	48,063	47,926
Retained Earnings	30,338	29,211	30,257	-8,400	-11,586	-23,187	-21,065	-22,874	-23,076
Accumulated Other Comprehensive Income / (Loss)	-9,822	-8,972	-12,394	-1,416	44	41	-791	-910	-1,500
Noncontrolling Interest	1,242	1,597	1,608	569	566	617	448	446	443

This table presents DuPont de Nemours' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Total Assets	41,355	41,208	40,797	39,133	38,552	37,717	36,553	37,461	36,636	35,981	36,559
Total Current Assets	11,270	11,200	11,127	7,935	7,514	7,067	6,163	6,439	6,364	6,464	6,850
Cash & Equivalents	3,662	3,525	4,885	1,338	2,392	1,934	1,503	1,645	1,850	1,762	1,837
Restricted Cash	7.00	-	111	409	411	413	6.00	6.00	6.00	5.00	5.00
Accounts Receivable	2,518	2,438	2,315	2,399	2,370	2,365	2,313	2,363	2,199	2,291	2,535
Inventories, net	2,329	2,443	2,341	2,279	2,147	2,175	2,164	2,237	2,130	2,242	2,295
Prepaid Expenses	161	157	160	196	194	180	177	188	179	164	178
Plant, Property, & Equipment, net	5,731	5,738	5,701	5,756	5,884	5,772	5,699	5,784	5,768	5,780	5,910
Total Noncurrent Assets	24,354	24,270	23,969	25,442	25,154	24,878	24,691	25,238	24,504	23,737	23,799
Long-Term Investments	733	744	757	751	1,071	1,086	1,112	1,120	1,081	1,071	1,112
Goodwill	16,663	16,703	16,643	17,251	16,720	16,613	16,558	16,868	16,567	15,947	16,240
Intangible Assets	5,495	5,366	5,190	6,038	5,814	5,640	5,477	5,579	5,370	5,251	5,163
Noncurrent Deferred & Refundable Income Taxes	109	112	112	103	312	288	281	287	246	245	252
Other Noncurrent Operating Assets	1,251	1,241	1,267	1,299	1,237	1,251	1,263	1,349	1,204	1,187	995
Other Noncurrent Nonoperating Assets	103	104	0.00	0.00	0.00	-	-	35	36	36	37
Total Liabilities & Shareholders' Equity	41,355	41,208	40,797	39,133	38,552	37,717	36,553	37,461	36,636	35,981	36,559
Total Liabilities	14,338	14,047	14,244	14,506	13,827	13,705	12,789	12,804	12,843	12,713	13,043
Total Current Liabilities	3,733	3,406	3,739	3,688	3,098	3,032	2,786	2,825	4,801	4,632	4,853
Short-Term Debt	300	300	300	475	0.00	-	-	-	1,848	1,849	1,849
Accounts Payable	2,103	1,921	1,768	1,685	1,675	1,624	1,655	1,702	1,720	1,657	1,699
Accrued Expenses	951	863	1,401	1,272	1,269	1,255	973	985	1,031	947	1,147
Current Deferred & Payable Income Tax Liabilities	233	186	135	119	154	153	158	138	202	179	158
Total Noncurrent Liabilities	10,605	10,641	10,505	10,818	10,729	10,673	10,003	9,979	8,042	8,081	8,190
Long-Term Debt	7,774	7,807	7,775	7,740	7,800	7,776	7,168	7,170	5,323	5,325	5,326
Noncurrent Deferred & Payable Income Tax Liabilities	1,158	1,145	1,028	1,326	1,130	1,098	1,045	1,027	915	897	844
Noncurrent Employee Benefit Liabilities	522	527	529	511	565	549	536	560	523	531	575
Other Noncurrent Operating Liabilities	1,151	1,162	1,173	1,241	1,234	1,250	1,254	1,222	1,281	1,328	1,445
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	27,017	27,161	26,553	24,627	24,725	24,012	23,764	24,657	23,793	23,268	23,516
Total Preferred & Common Equity	26,569	26,737	26,123	24,192	24,279	23,584	23,335	24,212	23,350	22,834	23,064
Total Common Equity	26,569	26,737	26,123	24,192	24,279	23,584	23,335	24,212	23,350	22,834	23,064
Common Stock	48,425	48,261	47,951	48,194	48,063	48,242	48,023	48,063	47,926	47,762	47,433
Retained Earnings	-21,065	-20,807	-20,938	-22,854	-22,874	-23,519	-23,414	-22,959	-23,076	-23,665	-23,606
Accumulated Other Comprehensive Income / (Loss)	-791	-717	-890	-1,148	-910	-1,139	-1,274	-892	-1,500	-1,263	-763
Noncontrolling Interest	448	424	430	435	446	428	429	445	443	434	452

This table displays calculated financial ratios and metrics derived from DuPont de Nemours' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-1.27%	-75.76%	93.57%	-31.68%	-27.91%	12.92%	3.59%	-7.29%	2.64%
EBITDA Growth	0.00%	-39.55%	-97.72%	1,258.86%	64.17%	-40.09%	28.60%	-0.27%	-33.47%	34.87%
EBIT Growth	0.00%	-52.67%	-118.33%	123.50%	119.23%	-265.57%	349.54%	-1.01%	-54.48%	76.44%
NOPAT Growth	0.00%	3.42%	-114.97%	111.76%	178.93%	-544.55%	249.71%	-15.62%	-35.60%	30.04%
Net Income Growth	0.00%	-43.42%	-70.69%	209.84%	-85.00%	-587.17%	322.89%	-9.18%	-92.19%	59.74%
EPS Growth	0.00%	-42.76%	-70.69%	209.84%	-86.49%	-698.51%	396.51%	-1.18%	-92.00%	77.66%
Operating Cash Flow Growth	0.00%	-138.87%	129.69%	526.77%	-74.40%	190.63%	-54.92%	-32.34%	75.42%	5.93%
Free Cash Flow Firm Growth	0.00%	0.00%	-156.64%	171.34%	-97.58%	1,542.67%	-74.76%	-69.49%	-83.88%	506.99%
Invested Capital Growth	0.00%	0.00%	222.39%	-49.56%	-2.00%	-41.58%	-12.79%	-1.74%	1.82%	-2.30%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	880.64%	163.77%	14.53%	27.44%	-1.08%	-1.68%	1.59%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	149.42%	1,509.39%	322.55%	-13.79%	7.57%	-28.82%	31.64%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	107.11%	118.64%	50.46%	-38.51%	-2.36%	-49.37%	75.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	105.53%	109.23%	35.64%	-49.27%	-9.62%	-26.13%	41.88%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	102.63%	-34.85%	1.42%	-0.06%	210.60%	-90.20%	-11.08%
EPS Q/Q Growth	0.00%	0.00%	0.00%	102.63%	-36.79%	1.72%	-4.42%	157.11%	-90.11%	-12.57%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	109.55%	-20.01%	-60.97%	222.94%	-79.28%	-0.08%	26.65%	-3.41%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-97.79%	1,015.81%	-76.80%	-78.79%	11.89%	93.93%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-52.07%	0.93%	-42.01%	-18.46%	-0.73%	-1.77%	-3.55%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	22.62%	21.78%	18.11%	32.27%	35.05%	36.53%	36.57%	35.45%	35.08%	36.39%
EBITDA Margin	26.08%	15.97%	1.50%	10.52%	25.29%	21.02%	23.94%	23.05%	16.54%	21.73%
Operating Margin	11.25%	9.25%	-8.15%	0.51%	2.02%	-12.46%	13.84%	12.86%	6.19%	12.71%
EBIT Margin	20.92%	10.03%	-7.58%	0.92%	2.95%	-6.78%	14.99%	14.33%	7.04%	12.09%
Profit (Net Income) Margin	15.96%	9.14%	11.06%	17.70%	3.89%	-26.27%	51.85%	45.46%	3.83%	5.96%
Tax Burden Percent	78.38%	99.80%	-84.66%	666.67%	-476.19%	232.17%	451.18%	408.63%	91.67%	61.91%
Interest Burden Percent	97.33%	91.39%	172.32%	288.46%	-27.63%	166.76%	76.65%	77.64%	59.36%	79.57%
Effective Tax Rate	21.62%	0.20%	0.00%	32.50%	0.00%	0.00%	16.41%	26.73%	-5.75%	34.73%
Return on Invested Capital (ROIC)	0.00%	25.22%	-0.89%	0.09%	0.38%	-2.18%	4.73%	4.32%	2.78%	3.63%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	24.15%	18.85%	-29.20%	-2.81%	-48.59%	-213.11%	350.60%	-10.21%	-3.50%
Return on Net Nonoperating Assets (RNNOA)	0.00%	7.13%	2.89%	3.95%	0.49%	-5.07%	14.98%	17.57%	-1.00%	-0.59%
Return on Equity (ROE)	0.00%	32.35%	2.00%	4.04%	0.87%	-7.25%	19.71%	21.89%	1.79%	3.04%
Cash Return on Invested Capital (CROIC)	0.00%	-174.78%	-106.19%	65.99%	2.40%	50.31%	18.39%	6.08%	0.98%	5.96%
Operating Return on Assets (OROA)	0.00%	6.07%	-0.65%	0.11%	0.35%	-1.08%	3.23%	4.28%	2.13%	3.98%
Return on Assets (ROA)	0.00%	5.54%	0.95%	2.11%	0.47%	-4.17%	11.17%	13.59%	1.16%	1.96%
Return on Common Equity (ROCE)	0.00%	30.87%	1.96%	3.98%	0.86%	-7.15%	19.35%	21.46%	1.75%	2.99%
Return on Equity Simple (ROE_SIMPLE)	0.00%	16.95%	1.29%	4.24%	1.46%	-7.59%	24.65%	22.27%	1.90%	3.16%
Net Operating Profit after Tax (NOPAT)	4,300	4,447	-666	78	218	-971	1,454	1,227	790	1,027
NOPAT Margin	8.82%	9.23%	-5.70%	0.35%	1.41%	-8.72%	11.57%	9.42%	6.55%	8.29%
Net Nonoperating Expense Percent (NNEP)	0.00%	1.07%	-19.75%	29.29%	3.19%	46.41%	217.84%	-346.28%	12.99%	7.12%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	3.50%	2.43%	3.32%
Cost of Revenue to Revenue	77.38%	78.22%	81.89%	67.73%	64.95%	63.47%	63.43%	64.55%	64.92%	63.61%
SG&A Expenses to Revenue	6.04%	6.13%	13.84%	13.40%	13.33%	13.41%	12.75%	11.27%	11.67%	12.53%
R&D to Revenue	3.28%	3.31%	5.63%	4.74%	4.46%	5.08%	4.43%	4.12%	4.21%	4.29%
Operating Expenses to Revenue	11.37%	12.53%	26.26%	31.76%	33.03%	48.99%	22.73%	22.59%	28.89%	23.68%
Earnings before Interest and Taxes (EBIT)	10,202	4,829	-885	208	456	-755	1,884	1,865	849	1,498
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	12,723	7,691	175	2,378	3,904	2,339	3,008	3,000	1,996	2,692
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	1.45	1.16	1.06	1.27	1.51	1.23	1.34	1.36
Price to Tangible Book Value (P/TBV)	0.00	0.00	19.36	2.43	0.00	4.17	12.33	7.43	18.60	22.55
Price to Revenue (P/Rev)	0.00	0.00	12.49	4.86	2.82	4.39	3.17	2.52	2.69	2.57
Price to Earnings (P/E)	0.00	0.00	125.73	28.56	87.45	0.00	6.16	5.59	76.72	45.33
Dividend Yield	0.00%	0.00%	0.61%	3.18%	1.66%	1.80%	1.56%	2.00%	1.91%	1.99%
Earnings Yield	0.00%	0.00%	0.80%	3.50%	1.14%	0.00%	16.24%	17.90%	1.30%	2.21%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.40	1.98	1.05	1.87	1.69	1.27	1.29	1.31
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	13.63	5.03	3.81	5.52	3.85	2.74	3.05	2.95
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	909.14	47.81	15.05	26.28	16.07	11.87	18.45	13.58
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	546.60	128.87	0.00	25.65	19.09	43.37	24.40
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	1,452.01	269.07	0.00	33.25	29.02	46.61	35.57
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	181.21	20.66	41.71	15.01	26.18	28.50	16.81	15.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	2.01	43.10	2.74	8.55	20.64	132.47	21.66
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.78	0.33	0.13	0.42	0.40	0.40	0.30	0.32	0.30
Long-Term Debt to Equity	0.00	0.75	0.29	0.13	0.33	0.40	0.39	0.29	0.32	0.22
Financial Leverage	0.00	0.30	0.15	-0.14	-0.17	0.10	-0.07	0.05	0.10	0.17
Leverage Ratio	0.00	2.92	2.10	1.92	1.87	1.74	1.76	1.61	1.54	1.55
Compound Leverage Factor	0.00	2.67	3.62	5.54	-0.52	2.90	1.35	1.25	0.92	1.23
Debt to Total Capital	0.00%	43.96%	25.05%	11.64%	29.57%	28.55%	28.50%	23.01%	23.98%	23.16%
Short-Term Debt to Total Capital	0.00%	1.87%	2.95%	0.01%	6.49%	0.00%	0.40%	0.85%	0.00%	5.97%
Long-Term Debt to Total Capital	0.00%	42.10%	22.10%	11.63%	23.08%	28.55%	28.10%	22.15%	23.98%	17.19%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	2.56%	1.17%	1.48%	0.96%	1.04%	1.63%	1.28%	1.37%	1.43%
Common Equity to Total Capital	0.00%	53.48%	73.77%	86.87%	69.47%	70.41%	69.87%	75.71%	74.65%	75.41%
Debt to EBITDA	0.00	2.78	194.69	5.32	4.47	6.67	3.58	2.69	3.91	2.66
Net Debt to EBITDA	0.00	1.05	67.30	0.96	3.75	5.14	2.62	0.79	1.97	1.57
Long-Term Debt to EBITDA	0.00	2.66	171.75	5.31	3.49	6.67	3.53	2.59	3.91	1.98
Debt to NOPAT	0.00	4.80	-51.18	161.42	79.89	-16.08	7.42	6.58	9.87	6.98
Net Debt to NOPAT	0.00	1.81	-17.69	29.23	67.07	-12.38	5.43	1.93	4.97	4.12
Long-Term Debt to NOPAT	0.00	4.60	-45.15	161.23	62.35	-16.08	7.31	6.34	9.87	5.18
Altman Z-Score	0.00	0.00	1.38	1.41	1.04	1.10	1.23	1.34	1.10	1.13
Noncontrolling Interest Sharing Ratio	0.00%	4.56%	2.20%	1.62%	1.58%	1.41%	1.79%	1.97%	1.73%	1.83%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.88	1.91	1.73	1.20	2.37	2.90	3.02	2.43	1.33
Quick Ratio	0.00	1.24	1.20	0.16	0.64	0.41	0.84	2.00	1.54	0.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-30,822	-79,101	56,434	1,363	22,396	5,653	1,725	278	1,687
Operating Cash Flow to CapEx	202.91%	-75.49%	0.00%	0.00%	57.00%	342.96%	234.26%	188.67%	353.96%	400.86%
Free Cash Flow to Firm to Interest Expense	0.00	-35.92	-78.55	1,026.08	2.04	33.33	10.77	3.51	0.70	4.61
Operating Cash Flow to Interest Expense	8.04	-3.45	0.87	100.05	2.11	6.09	3.52	2.54	5.53	6.34
Operating Cash Flow Less CapEx to Interest Expense	4.08	-8.01	0.87	100.05	-1.59	4.32	2.02	1.19	3.97	4.76
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.61	0.09	0.12	0.12	0.16	0.22	0.30	0.30	0.33
Accounts Receivable Turnover	0.00	5.36	0.90	2.23	4.29	3.58	5.49	5.57	4.94	5.42
Inventory Turnover	0.00	5.12	0.78	1.45	2.38	2.10	3.56	3.81	3.50	3.68
Fixed Asset Turnover	0.00	2.05	0.39	0.98	1.54	1.31	1.99	2.27	2.08	2.13
Accounts Payable Turnover	0.00	5.69	0.98	1.98	3.61	2.74	3.69	4.00	4.15	4.64
Days Sales Outstanding (DSO)	0.00	68.05	404.51	163.84	85.04	102.06	66.52	65.57	73.92	67.32
Days Inventory Outstanding (DIO)	0.00	71.35	465.03	251.64	153.38	173.43	102.55	95.90	104.26	99.07
Days Payable Outstanding (DPO)	0.00	64.11	371.89	184.62	101.08	133.23	99.00	91.34	88.00	78.64
Cash Conversion Cycle (CCC)	0.00	75.28	497.65	230.86	137.34	142.26	70.07	70.13	90.18	87.75
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	35,269	113,704	57,348	56,203	32,836	28,637	28,139	28,651	27,991
Invested Capital Turnover	0.00	2.73	0.16	0.26	0.27	0.25	0.41	0.46	0.43	0.44
Increase / (Decrease) in Invested Capital	0.00	35,269	78,435	-56,356	-1,145	-23,367	-4,199	-498	512	-660
Enterprise Value (EV)	0.00	0.00	159,100	113,693	58,765	61,457	48,329	35,601	36,825	36,546
Market Capitalization	0.00	0.00	145,726	109,796	43,549	48,870	39,821	32,783	32,453	31,869
Book Value per Share	$0.00	$23.45	$42.88	$41.10	$55.33	$52.47	$51.02	$53.48	$56.46	$55.87
Tangible Book Value per Share	$0.00	$4.23	$3.22	$19.68	($7.77)	$15.98	$6.23	$8.88	$4.06	$3.38
Total Capital	0.00	48,592	135,998	108,539	59,003	54,682	37,832	35,091	32,525	30,964
Total Debt	0.00	21,363	34,071	12,639	17,447	15,612	10,782	8,074	7,800	7,171
Total Long-Term Debt	0.00	20,456	30,056	12,624	13,617	15,611	10,632	7,774	7,800	5,323
Net Debt	0.00	8,040	11,777	2,289	14,647	12,021	7,891	2,370	3,926	4,234
Capital Expenditures (CapEx)	3,749	3,917	0.00	0.00	2,472	1,194	788	662	619	579
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	5,355	13,386	44,781	3,943	14,239	7,550	2,866	1,613	1,555
Debt-free Net Working Capital (DFNWC)	0.00	11,962	27,780	53,358	5,483	16,783	9,522	7,837	4,416	3,411
Net Working Capital (NWC)	0.00	11,055	23,765	53,343	1,653	16,782	9,372	7,537	4,416	1,563
Net Nonoperating Expense (NNE)	-3,483	43	-1,957	-3,922	-382	1,952	-5,061	-4,690	328	289
Net Nonoperating Obligations (NNO)	0.00	8,040	11,777	-38,552	14,647	-6,234	1,587	1,122	3,926	4,198
Total Depreciation and Amortization (D&A)	2,521	2,862	1,060	2,170	3,448	3,094	1,124	1,135	1,147	1,194
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	11.12%	114.68%	198.20%	25.54%	127.96%	60.08%	22.02%	13.37%	12.55%
Debt-free Net Working Capital to Revenue	0.00%	24.84%	238.01%	236.16%	35.52%	150.82%	75.78%	60.21%	36.59%	27.54%
Net Working Capital to Revenue	0.00%	22.96%	203.61%	236.09%	10.71%	150.81%	74.58%	57.90%	36.59%	12.62%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.43	$0.78	$0.67	($4.01)	$11.92	$11.77	$0.94	$1.68
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	3.36B	4.89B	746.30M	735.50M	542.70M	498.50M	449.90M	419.20M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.43	$0.78	$0.67	($4.01)	$11.89	$11.75	$0.94	$1.67
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	3.40B	4.92B	746.30M	735.50M	544.20M	499.40M	451.20M	420.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.67	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	4.95B	4.79B	739.39M	1.08B	512.91M	458.34M	417.58M	418.05M
Normalized Net Operating Profit after Tax (NOPAT)	4,738	5,041	-464	178	494	1,026	1,563	1,482	1,202	1,194
Normalized NOPAT Margin	9.71%	10.47%	-3.98%	0.79%	3.20%	9.22%	12.44%	11.38%	9.96%	9.64%
Pre Tax Income Margin	20.36%	9.16%	-13.07%	2.66%	-0.82%	-11.31%	11.49%	11.12%	4.18%	9.62%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.78	5.63	-0.88	3.78	0.68	-1.12	3.59	3.79	2.14	4.09
NOPAT to Interest Expense	4.55	5.18	-0.66	1.42	0.33	-1.44	2.77	2.49	1.99	2.81
EBIT Less CapEx to Interest Expense	6.82	1.06	-0.88	3.78	-3.02	-2.90	2.09	2.45	0.58	2.51
NOPAT Less CapEx to Interest Expense	0.58	0.62	-0.66	1.42	-3.38	-3.22	1.27	1.15	0.43	1.22
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	32.64%	64.49%	0.00%	87.28%	1,492.17%	-31.89%	10.12%	11.46%	148.92%	89.57%
Augmented Payout Ratio	47.62%	85.29%	0.00%	87.28%	1,880.33%	-31.89%	10.12%	11.46%	148.92%	89.57%

This table displays calculated financial ratios and metrics derived from DuPont de Nemours' official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.37%	-7.82%	-6.86%	-7.81%	-6.64%	-2.88%	2.49%	4.38%	6.69%	4.61%	2.71%
EBITDA Growth	57.81%	-0.28%	-11.52%	-11.20%	-140.28%	-9.96%	-7.20%	21.69%	278.88%	-108.10%	-2.09%
EBIT Growth	-12.97%	16.89%	-24.14%	-18.20%	-274.17%	-19.50%	-15.45%	32.06%	122.05%	-198.29%	-3.23%
NOPAT Growth	-50.46%	1.44%	-16.11%	-24.78%	-383.73%	-31.27%	-12.33%	18.98%	-34.32%	-245.53%	6.30%
Net Income Growth	1,775.22%	-47.83%	-114.72%	-12.77%	-100.33%	-25.66%	258.12%	40.85%	-657.14%	-395.43%	-62.16%
EPS Growth	535.82%	-41.05%	-118.06%	-4.11%	-100.47%	-19.64%	250.00%	54.29%	-600.00%	-413.33%	-66.67%
Operating Cash Flow Growth	-0.54%	93.78%	44.40%	28.03%	249.19%	21.73%	31.75%	-0.41%	-12.69%	-22.52%	-27.70%
Free Cash Flow Firm Growth	-85.97%	-82.47%	-72.72%	-107.01%	-239.64%	-66.73%	-126.47%	203.66%	120.02%	87.28%	362.65%
Invested Capital Growth	-1.74%	-1.56%	-3.43%	2.90%	1.82%	-0.14%	2.22%	-0.50%	-2.30%	-2.78%	-2.16%
Revenue Q/Q Growth	-6.42%	-2.77%	2.52%	-1.16%	-5.23%	1.14%	8.19%	0.66%	-3.13%	-0.84%	6.23%
EBITDA Q/Q Growth	-35.50%	23.78%	1.26%	9.83%	-129.26%	376.72%	4.36%	44.03%	-56.99%	-112.53%	1,361.54%
EBIT Q/Q Growth	-50.49%	44.37%	0.92%	13.41%	-205.41%	166.73%	5.98%	77.15%	-82.40%	-397.41%	204.35%
NOPAT Q/Q Growth	-69.76%	145.17%	-0.25%	1.72%	-214.06%	159.39%	27.22%	38.06%	-228.76%	35.65%	192.92%
Net Income Q/Q Growth	1,027.13%	-93.75%	-144.15%	380.34%	-104.27%	1,507.14%	-6.09%	149.73%	-122.94%	-449.06%	112.03%
EPS Q/Q Growth	1,067.12%	-93.43%	-150.00%	350.00%	-105.71%	1,225.00%	-6.67%	157.14%	-125.93%	-403.57%	109.93%
Operating Cash Flow Q/Q Growth	-67.99%	118.92%	-1.23%	85.00%	-12.70%	-23.68%	6.90%	39.85%	-23.47%	-32.27%	-0.26%
Free Cash Flow Firm Q/Q Growth	-91.31%	21.88%	70.10%	-138.90%	-73.14%	129.03%	-235.32%	252.38%	-66.56%	171.57%	89.79%
Invested Capital Q/Q Growth	-0.73%	0.91%	-2.46%	5.32%	-1.77%	-1.03%	-0.16%	2.51%	-3.55%	-1.51%	0.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	34.02%	34.29%	34.39%	36.10%	35.54%	34.56%	37.05%	37.41%	36.38%	37.38%	37.34%
EBITDA Margin	18.56%	23.62%	23.34%	25.93%	-8.01%	21.90%	21.13%	30.23%	13.42%	-1.70%	20.14%
Operating Margin	7.54%	13.49%	13.32%	14.52%	-17.81%	10.68%	14.47%	14.41%	11.06%	-14.55%	11.45%
EBIT Margin	9.73%	14.45%	14.22%	16.32%	-18.15%	11.98%	11.73%	20.65%	3.75%	-11.25%	11.05%
Profit (Net Income) Margin	136.53%	8.78%	-3.78%	10.73%	-0.48%	6.72%	5.83%	14.47%	-3.43%	-18.98%	2.15%
Tax Burden Percent	2,195.85%	74.44%	-32.87%	80.39%	2.27%	73.78%	62.50%	78.84%	-246.51%	135.66%	22.88%
Interest Burden Percent	63.91%	81.65%	80.91%	81.76%	117.11%	76.07%	79.57%	88.92%	37.07%	124.35%	85.00%
Effective Tax Rate	45.60%	23.31%	24.44%	28.68%	0.00%	31.46%	40.54%	18.09%	241.86%	0.00%	22.22%
Return on Invested Capital (ROIC)	1.88%	4.61%	4.47%	4.42%	-5.30%	3.09%	3.71%	4.95%	-6.86%	-4.56%	4.01%
ROIC Less NNEP Spread (ROIC-NNEP)	305.36%	1.74%	-18.77%	4.73%	8.46%	2.46%	0.62%	6.86%	2.47%	-10.80%	-1.03%
Return on Net Nonoperating Assets (RNNOA)	15.30%	0.11%	-1.31%	0.70%	0.83%	0.27%	0.07%	1.24%	0.41%	-1.97%	-0.19%
Return on Equity (ROE)	17.18%	4.72%	3.16%	5.12%	-4.47%	3.36%	3.78%	6.19%	-6.45%	-6.53%	3.82%
Cash Return on Invested Capital (CROIC)	6.08%	5.89%	7.66%	0.86%	0.98%	2.59%	0.26%	2.99%	5.96%	3.09%	2.74%
Operating Return on Assets (OROA)	2.91%	4.26%	4.18%	4.81%	-5.48%	3.64%	3.66%	6.57%	1.24%	-3.82%	3.81%
Return on Assets (ROA)	40.83%	2.59%	-1.11%	3.16%	-0.15%	2.04%	1.82%	4.61%	-1.13%	-6.45%	0.74%
Return on Common Equity (ROCE)	16.84%	4.63%	3.10%	5.01%	-4.39%	3.30%	3.71%	6.08%	-6.33%	-6.42%	3.75%
Return on Equity Simple (ROE_SIMPLE)	0.00%	21.22%	18.23%	19.49%	0.00%	1.67%	2.98%	3.43%	0.00%	-0.18%	0.00%
Net Operating Profit after Tax (NOPAT)	127	312	311	317	-361	215	273	377	-485	-312	290
NOPAT Margin	4.10%	10.34%	10.06%	10.36%	-12.46%	7.32%	8.61%	11.80%	-15.69%	-10.18%	8.91%
Net Nonoperating Expense Percent (NNEP)	-303.48%	2.87%	23.25%	-0.31%	-13.76%	0.63%	3.09%	-1.91%	-9.33%	6.24%	5.04%
Return On Investment Capital (ROIC_SIMPLE)	0.36%	-	-	-	-1.11%	-	-	-	-1.57%	-1.03%	0.95%
Cost of Revenue to Revenue	65.98%	65.71%	65.61%	63.90%	64.46%	65.44%	62.95%	62.59%	63.62%	62.62%	62.67%
SG&A Expenses to Revenue	10.86%	11.27%	11.57%	11.77%	12.08%	13.10%	13.18%	12.12%	11.74%	12.04%	12.43%
R&D to Revenue	3.96%	4.21%	4.04%	4.19%	4.42%	4.26%	4.23%	4.20%	4.46%	4.47%	4.36%
Operating Expenses to Revenue	26.48%	20.81%	21.07%	21.58%	53.35%	23.88%	22.58%	23.00%	25.32%	51.92%	25.88%
Earnings before Interest and Taxes (EBIT)	302	436	440	499	-526	351	372	659	116	-345	360
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	576	713	722	793	-232	642	670	965	415	-52	656
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.23	1.20	1.23	1.39	1.34	1.39	1.44	1.54	1.36	1.37	1.24
Price to Tangible Book Value (P/TBV)	7.43	6.87	7.49	37.18	18.60	24.66	25.89	21.08	22.55	19.08	17.28
Price to Revenue (P/Rev)	2.52	2.51	2.57	2.74	2.69	2.74	2.79	3.05	2.57	2.49	2.28
Price to Earnings (P/E)	5.59	5.69	6.81	7.19	76.72	92.45	50.68	46.56	45.33	0.00	0.00
Dividend Yield	2.00%	1.93%	1.97%	1.93%	1.91%	1.91%	1.84%	1.68%	1.99%	2.08%	2.30%
Earnings Yield	17.90%	17.57%	14.68%	13.91%	1.30%	1.08%	1.97%	2.15%	2.21%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.27	1.23	1.26	1.36	1.29	1.33	1.36	1.45	1.31	1.31	1.21
Enterprise Value to Revenue (EV/Rev)	2.74	2.74	2.78	3.24	3.05	3.14	3.20	3.45	2.95	2.87	2.65
Enterprise Value to EBITDA (EV/EBITDA)	11.87	11.68	12.02	14.17	18.45	19.53	20.62	20.56	13.58	18.01	16.82
Enterprise Value to EBIT (EV/EBIT)	19.09	18.16	19.52	23.69	43.37	49.20	55.50	49.12	24.40	44.88	42.25
Enterprise Value to NOPAT (EV/NOPAT)	29.02	28.32	29.73	37.14	46.61	53.93	55.97	58.07	35.57	466.02	212.55
Enterprise Value to Operating Cash Flow (EV/OCF)	28.50	24.24	22.26	22.96	16.81	16.49	16.06	17.50	15.75	16.29	16.17
Enterprise Value to Free Cash Flow (EV/FCFF)	20.64	20.77	16.17	159.89	132.47	51.07	521.02	48.33	21.66	41.64	43.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.30	0.30	0.30	0.33	0.32	0.32	0.30	0.29	0.30	0.31	0.31
Long-Term Debt to Equity	0.29	0.29	0.29	0.31	0.32	0.32	0.30	0.29	0.22	0.23	0.23
Financial Leverage	0.05	0.06	0.07	0.15	0.10	0.11	0.11	0.18	0.17	0.18	0.18
Leverage Ratio	1.61	1.61	1.62	1.66	1.54	1.54	1.54	1.55	1.55	1.56	1.55
Compound Leverage Factor	1.03	1.31	1.31	1.36	1.81	1.17	1.22	1.38	0.57	1.94	1.31
Debt to Total Capital	23.01%	22.99%	23.32%	25.01%	23.98%	24.46%	23.17%	22.53%	23.16%	23.57%	23.38%
Short-Term Debt to Total Capital	0.85%	0.85%	0.87%	1.45%	0.00%	0.00%	0.00%	0.00%	5.97%	6.07%	6.02%
Long-Term Debt to Total Capital	22.15%	22.14%	22.45%	23.57%	23.98%	24.46%	23.17%	22.53%	17.19%	17.49%	17.35%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.28%	1.20%	1.24%	1.32%	1.37%	1.35%	1.39%	1.40%	1.43%	1.43%	1.47%
Common Equity to Total Capital	75.71%	75.81%	75.44%	73.66%	74.65%	74.19%	75.44%	76.07%	75.41%	75.01%	75.15%
Debt to EBITDA	2.69	2.70	2.78	2.93	3.91	4.04	3.83	3.51	2.66	3.59	3.62
Net Debt to EBITDA	0.79	0.84	0.80	2.04	1.97	2.26	2.43	2.15	1.57	2.17	2.13
Long-Term Debt to EBITDA	2.59	2.60	2.68	2.76	3.91	4.04	3.83	3.51	1.98	2.67	2.68
Debt to NOPAT	6.58	6.56	6.88	7.68	9.87	11.16	10.39	9.90	6.98	92.89	45.69
Net Debt to NOPAT	1.93	2.04	1.98	5.35	4.97	6.23	6.59	6.08	4.12	56.15	26.88
Long-Term Debt to NOPAT	6.34	6.31	6.62	7.24	9.87	11.16	10.39	9.90	5.18	68.95	33.92
Altman Z-Score	1.22	1.23	1.20	1.06	0.98	1.04	1.16	1.38	1.01	0.93	0.86
Noncontrolling Interest Sharing Ratio	1.97%	1.93%	1.97%	2.05%	1.73%	1.66%	1.71%	1.79%	1.83%	1.82%	1.86%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.02	3.29	2.98	2.15	2.43	2.33	2.21	2.28	1.33	1.40	1.41
Quick Ratio	2.00	2.14	1.93	1.01	1.54	1.42	1.37	1.42	0.84	0.88	0.90
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	625	762	1,296	-504	-873	254	-343	523	175	475	901
Operating Cash Flow to CapEx	115.63%	174.57%	325.20%	621.85%	445.52%	238.16%	516.67%	676.15%	350.31%	153.41%	328.45%
Free Cash Flow to Firm to Interest Expense	5.13	8.02	13.23	-4.94	-8.65	2.64	-3.47	6.01	2.08	5.72	10.73
Operating Cash Flow to Interest Expense	1.52	4.26	4.08	7.25	6.40	5.14	5.32	8.47	6.71	4.60	4.54
Operating Cash Flow Less CapEx to Interest Expense	0.20	1.82	2.83	6.09	4.96	2.98	4.29	7.22	4.80	1.60	3.15
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.30	0.29	0.29	0.29	0.30	0.30	0.31	0.32	0.33	0.34	0.34
Accounts Receivable Turnover	5.57	5.36	5.47	5.27	4.94	4.99	5.21	5.12	5.42	5.38	5.20
Inventory Turnover	3.81	3.54	3.47	3.46	3.50	3.37	3.43	3.45	3.68	3.57	3.56
Fixed Asset Turnover	2.27	2.24	2.23	2.19	2.08	2.08	2.12	2.11	2.13	2.17	2.17
Accounts Payable Turnover	4.00	4.04	4.18	4.28	4.15	4.38	4.52	4.59	4.64	4.80	4.73
Days Sales Outstanding (DSO)	65.57	68.15	66.72	69.23	73.92	73.16	70.05	71.28	67.32	67.86	70.18
Days Inventory Outstanding (DIO)	95.90	103.24	105.10	105.61	104.26	108.47	106.28	105.93	99.07	102.28	102.67
Days Payable Outstanding (DPO)	91.34	90.36	87.33	85.30	88.00	83.26	80.75	79.45	78.64	75.98	77.23
Cash Conversion Cycle (CCC)	70.13	81.03	84.49	89.54	90.18	98.36	95.57	97.77	87.75	94.17	95.62
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	28,139	28,394	27,695	29,167	28,651	28,355	28,311	29,021	27,991	27,568	27,700
Invested Capital Turnover	0.46	0.45	0.44	0.43	0.43	0.42	0.43	0.42	0.44	0.45	0.45
Increase / (Decrease) in Invested Capital	-498	-450	-985	821	512	-39	616	-146	-660	-787	-611
Enterprise Value (EV)	35,601	35,020	34,900	39,723	36,825	37,589	38,629	42,047	36,546	35,990	33,378
Market Capitalization	32,783	32,077	32,148	33,571	32,453	32,818	33,653	37,203	31,869	31,220	28,705
Book Value per Share	$53.48	$58.33	$56.91	$52.70	$56.46	$55.78	$55.81	$57.99	$55.87	$54.62	$55.11
Tangible Book Value per Share	$8.88	$10.18	$9.35	$1.97	$4.06	$3.15	$3.11	$4.23	$3.38	$3.91	$3.97
Total Capital	35,091	35,268	34,628	32,842	32,525	31,788	30,932	31,827	30,964	30,442	30,691
Total Debt	8,074	8,107	8,075	8,215	7,800	7,776	7,168	7,170	7,171	7,174	7,175
Total Long-Term Debt	7,774	7,807	7,775	7,740	7,800	7,776	7,168	7,170	5,323	5,325	5,326
Net Debt	2,370	2,519	2,322	5,717	3,926	4,343	4,547	4,399	4,234	4,336	4,221
Capital Expenditures (CapEx)	160	232	123	119	145	207	102	109	161	249	116
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,866	3,250	2,692	2,975	1,613	1,688	1,868	1,963	1,555	1,914	2,004
Debt-free Net Working Capital (DFNWC)	7,837	8,094	7,688	4,722	4,416	4,035	3,377	3,614	3,411	3,681	3,846
Net Working Capital (NWC)	7,537	7,794	7,388	4,247	4,416	4,035	3,377	3,614	1,563	1,832	1,997
Net Nonoperating Expense (NNE)	-4,111	47	428	-11	-347	18	88	-85	-379	270	220
Net Nonoperating Obligations (NNO)	1,122	1,233	1,142	4,540	3,926	4,343	4,547	4,364	4,198	4,300	4,184
Total Depreciation and Amortization (D&A)	274	277	282	294	294	291	298	306	299	293	296
Debt-free, Cash-free Net Working Capital to Revenue	22.02%	25.47%	21.48%	24.24%	13.37%	14.09%	15.49%	16.10%	12.55%	15.29%	15.90%
Debt-free Net Working Capital to Revenue	60.21%	63.43%	61.34%	38.47%	36.59%	33.68%	28.01%	29.64%	27.54%	29.40%	30.51%
Net Working Capital to Revenue	57.90%	61.08%	58.95%	34.60%	36.59%	33.68%	28.01%	29.64%	12.62%	14.63%	15.84%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$8.53	$0.56	($0.29)	$0.71	($0.04)	$0.45	$0.43	$1.09	($0.29)	($1.41)	$0.14
Adjusted Weighted Average Basic Shares Outstanding	498.50M	458.80M	459.20M	451.70M	449.90M	422.80M	417.80M	417.90M	419.20M	418.50M	418.90M
Adjusted Diluted Earnings per Share	$8.52	$0.56	($0.28)	$0.70	($0.04)	$0.45	$0.42	$1.08	($0.28)	($1.41)	$0.14
Adjusted Weighted Average Diluted Shares Outstanding	499.40M	460.20M	460.30M	453.40M	451.20M	424.30M	419.30M	419.50M	420.60M	418.50M	419.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	458.34M	459.02M	459.06M	430.04M	417.58M	418.10M	417.50M	417.96M	418.05M	418.50M	418.72M
Normalized Net Operating Profit after Tax (NOPAT)	262	323	324	322	-272	241	278	394	370	258	292
Normalized NOPAT Margin	8.43%	10.70%	10.48%	10.54%	-9.40%	8.23%	8.76%	12.34%	11.98%	8.42%	8.96%
Pre Tax Income Margin	6.22%	11.80%	11.51%	13.34%	-21.26%	9.11%	9.33%	18.36%	1.39%	-13.99%	9.40%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.48	4.59	4.49	4.89	-5.21	3.66	3.76	7.57	1.38	-4.16	4.29
NOPAT to Interest Expense	1.04	3.29	3.18	3.10	-3.58	2.23	2.76	4.33	-5.78	-3.76	3.45
EBIT Less CapEx to Interest Expense	1.16	2.15	3.23	3.73	-6.64	1.50	2.73	6.32	-0.54	-7.16	2.90
NOPAT Less CapEx to Interest Expense	-0.27	0.84	1.92	1.94	-5.01	0.08	1.73	3.08	-7.69	-6.76	2.07
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	11.46%	12.16%	14.53%	14.43%	148.92%	169.54%	94.97%	79.40%	89.57%	-1,648.78%	-441.67%
Augmented Payout Ratio	11.46%	12.16%	14.53%	14.43%	148.92%	169.54%	94.97%	79.40%	89.57%	-1,648.78%	-441.67%

Key Financial Trends

DuPont de Nemours (NYSE: DD) has shown signs of recovery and improvement in its financial performance through the most recent quarters, following some challenging periods in 2024.

Positive Highlights:

In Q2 2025, DuPont reported a consolidated net income of $70 million, a significant improvement compared to previous losses in 2024.
Net income from continuing operations increased robustly to $238 million in Q2 2025, signaling core business strength.
Operating revenue steadily increased, reaching $3.26 billion in Q2 2025, up from $3.09 billion in Q4 2024, indicating growth in sales.
Operating gross profit expanded to $1.22 billion in Q2 2025 from $1.13 billion in Q4 2024, driven by controlled operating costs and higher revenues.
Strong cash flow from continuing operating activities at $381 million in Q2 2025, consistent with $382 million in Q1 2025, supporting operational stability.
Cash and equivalents increased to $1.84 billion at the end of Q2 2025, up from $1.76 billion in Q1 2025, enhancing liquidity.
Total liabilities remained manageable relative to total assets of $36.56 billion as of Q2 2025, maintaining a solid balance sheet structure.
The company continues to invest in property, plant, and equipment with $116 million outflow in Q2 2025, supporting future capacity.

Neutral Observations:

DuPont paid $171 million in dividends in Q2 2025, consistent with its dividend policy, reflecting shareholder returns.
The company has ongoing restructuring and other operating charges, but these expenses have decreased from historical highs, such as the $200 million restructuring charge in Q4 2024.

Negative Trends:

Discontinued operations continue to negatively impact results, with a loss of $168 million in Q2 2025 affecting consolidated net income.
Net income was significantly negative in early 2024 quarters, including a $582 million loss in Q1 2025 and a $118 million loss in Q4 2024, showing prior volatility.
Interest expenses remain high, around $84 million in Q2 2025, which pressures net income amid rising debt levels.
The company recorded high dividend payments against relatively modest net income in recent quarters, which could raise sustainability questions if profitability does not strengthen.
Previous impairment and restructuring charges were substantial in 2024, such as a $768 million impairment in Q1 2025 and $187 million restructuring in Q4 2024, reflecting operational challenges.

Summary: DuPont's financials from 2023 through mid-2025 demonstrate a company recovering from significant losses and restructuring efforts. Revenue and operating income have generally improved, and operating cash flow is stable, supporting reinvestment and shareholder payouts. However, challenges persist including discontinued operations losses, debt-related interest expenses, and elevated dividend payments relative to net income.

Investors should watch upcoming quarters for continued profitability improvements and any changes in discontinued operations or restructuring impacts. The company's strong asset base and cash flow generation are positive signs as it navigates through operational transitions.

08/29/25 08:17 AM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About DuPont de Nemours' Financials

When does DuPont de Nemours' financial year end?

According to the most recent income statement we have on file, DuPont de Nemours' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has DuPont de Nemours' net income changed over the last 9 years?

DuPont de Nemours' net income appears to be on a downward trend, with a most recent value of $738 million in 2024, falling from $7.78 billion in 2015. The previous period was $462 million in 2023. Find out what analysts predict for DuPont de Nemours in the coming months.

What is DuPont de Nemours' operating income?

DuPont de Nemours' total operating income in 2024 was $1.57 billion, based on the following breakdown:

Total Gross Profit: $4.51 billion
Total Operating Expenses: $2.93 billion

How has DuPont de Nemours' revenue changed over the last 9 years?

Over the last 9 years, DuPont de Nemours' total revenue changed from $48.78 billion in 2015 to $12.39 billion in 2024, a change of -74.6%.

How much debt does DuPont de Nemours have?

DuPont de Nemours' total liabilities were at $12.84 billion at the end of 2024, a 7.1% decrease from 2023, and a 75.4% decrease since 2016.

How much cash does DuPont de Nemours have?

In the past 8 years, DuPont de Nemours' cash and equivalents has ranged from $1.54 billion in 2019 to $13.44 billion in 2017, and is currently $1.85 billion as of their latest financial filing in 2024.

How has DuPont de Nemours' book value per share changed over the last 9 years?

Over the last 9 years, DuPont de Nemours' book value per share changed from 0.00 in 2015 to 55.87 in 2024, a change of 5,586.7%.

Related Companies

This page (NYSE:DD) was last updated on 8/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DuPont de Nemours (DD) Financials

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About DuPont de Nemours' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DuPont de Nemours (DD) Financials

Annual Income Statements for DuPont de Nemours

Quarterly Income Statements for DuPont de Nemours

Annual Cash Flow Statements for DuPont de Nemours

Quarterly Cash Flow Statements for DuPont de Nemours

Annual Balance Sheets for DuPont de Nemours

Quarterly Balance Sheets for DuPont de Nemours

Annual Metrics And Ratios for DuPont de Nemours

Quarterly Metrics And Ratios for DuPont de Nemours

Key Financial Trends

Financials Breakdown Chart

Frequently Asked Questions About DuPont de Nemours' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools